Literature DB >> 15855601

The use of U-500 in patients with extreme insulin resistance.

Elaine Cochran1, Carla Musso, Phillip Gorden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15855601     DOI： 10.2337/diacare.28.5.1240

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  34 in total

1.  U-500 insulin as a component of basal bolus insulin therapy in type 2 diabetes.

Authors:  Jolene Brown Lowery; Amy C Donihi; Mary T Korytkowski
Journal:  Diabetes Technol Ther       Date:  2012-02-24       Impact factor: 6.118

2.  Continuous subcutaneous IGF-1 therapy via insulin pump in a patient with Donohue syndrome.

Authors:  David R Weber; Diana E Stanescu; Robert Semple; Cheryl Holland; Sheela N Magge
Journal:  J Pediatr Endocrinol Metab       Date:  2014-11       Impact factor: 1.634

Review 3.  Clinical use of U-500 regular insulin: review and meta-analysis.

Authors:  Sirimon Reutrakul; Kristen Wroblewski; Rebecca L Brown
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

Review 4.  Polymeric nanoparticle drug delivery technologies for oral delivery applications.

Authors:  Eric M Pridgen; Frank Alexis; Omid C Farokhzad
Journal:  Expert Opin Drug Deliv       Date:  2015-03-26       Impact factor: 6.648

Review 5.  Insulin receptor signaling in normal and insulin-resistant states.

Authors:  Jérémie Boucher; André Kleinridders; C Ronald Kahn
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-01-01       Impact factor: 10.005

Review 6.  Polymeric nanoparticle technologies for oral drug delivery.

Authors:  Eric M Pridgen; Frank Alexis; Omid C Farokhzad
Journal:  Clin Gastroenterol Hepatol       Date:  2014-06-27       Impact factor: 11.382

7.  Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes.

Authors:  Yevgeniya S Kushchayeva; Sergiy V Kushchayev; Megan Startzell; Elaine Cochran; Sungyoung Auh; Yuhai Dai; Marissa Lightbourne; Monica Skarulis; Rebecca J Brown
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

Review 8.  Are you ready for more insulin concentrations?

Authors:  Alissa R Segal; Nuha El Sayed
Journal:  J Diabetes Sci Technol       Date:  2014-11-10

9.  Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery.

Authors:  Eric M Pridgen; Frank Alexis; Timothy T Kuo; Etgar Levy-Nissenbaum; Rohit Karnik; Richard S Blumberg; Robert Langer; Omid C Farokhzad
Journal:  Sci Transl Med       Date:  2013-11-27       Impact factor: 17.956

10.  U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients.

Authors:  Mayer B Davidson; Maria D Navar; Diana Echeverry; Petra Duran
Journal:  Diabetes Care       Date:  2009-11-12       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.